aldosterone has been researched along with Hyperprolactinemia in 10 studies
Hyperprolactinemia: Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study was to evaluate the relationship of nontumoural hyperprolactinemia with the activity of adrenocortical and RAA axis, before and after administration of bromocriptine." | 9.15 | The renin-angiotensin-aldosterone axis in patients with nontumoral [corrected] hyperprolactinemia. ( Chlorou, A; Kotsa, K; Mediskou, P; Papazisi, A; Psarakou-Gotzamani, A; Tsekmekidou, X; Yavropoulou, MP; Yovos, JG, 2011) |
| "These results suggest that hyperprolactinemia increases basal, angiotensin II- and KCl-stimulated aldosterone secretion by ZG cells in OVX rats through activation of T-type Ca2+ channels, the post-cAMP and protein kinase A pathway, cytochrome P450 side-chain cleavage enzyme, and aldosterone synthase, as well as by causing increased expression of steroidogenic acute regulatory protein in ZG cells." | 7.71 | Stimulatory effects of hyperprolactinemia on aldosterone secretion in ovariectomized rats. ( Chang, LL; Ho, LT; Kan, SF; Kau, MM; Wang, PS, 2002) |
| " The aim of this study was to evaluate the relationship of nontumoural hyperprolactinemia with the activity of adrenocortical and RAA axis, before and after administration of bromocriptine." | 5.15 | The renin-angiotensin-aldosterone axis in patients with nontumoral [corrected] hyperprolactinemia. ( Chlorou, A; Kotsa, K; Mediskou, P; Papazisi, A; Psarakou-Gotzamani, A; Tsekmekidou, X; Yavropoulou, MP; Yovos, JG, 2011) |
| "These results suggest that hyperprolactinemia increases basal, angiotensin II- and KCl-stimulated aldosterone secretion by ZG cells in OVX rats through activation of T-type Ca2+ channels, the post-cAMP and protein kinase A pathway, cytochrome P450 side-chain cleavage enzyme, and aldosterone synthase, as well as by causing increased expression of steroidogenic acute regulatory protein in ZG cells." | 3.71 | Stimulatory effects of hyperprolactinemia on aldosterone secretion in ovariectomized rats. ( Chang, LL; Ho, LT; Kan, SF; Kau, MM; Wang, PS, 2002) |
| " The hyperprolactinemia, hypogonadotropic hypogonadism, hyperaldosteronism and hypokalemia subsided with the administration of bromocriptine 5 mg/day." | 3.68 | Hyperiodotyrosinemia-induced hyperprolactinemia and hyperaldosteronism. ( Tan, LG; Tan, SA, 1990) |
| "Seven women with untreated chronic hyperprolactinemia (HPRL) were included in the study." | 1.27 | Lack of prolactin involvement in corticosteroid secretion. ( Girard, F; Hugues, JN; Modigliani, E; Sebaoun, J, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mediskou, P | 1 |
| Yavropoulou, MP | 1 |
| Kotsa, K | 1 |
| Tsekmekidou, X | 1 |
| Psarakou-Gotzamani, A | 1 |
| Papazisi, A | 1 |
| Chlorou, A | 1 |
| Yovos, JG | 1 |
| Oki, Y | 1 |
| Yagi, T | 1 |
| Yoshimi, T | 1 |
| Mychka, VB | 1 |
| Chazova, IE | 1 |
| Dmitriev, VV | 1 |
| Masenko, VP | 1 |
| Kau, MM | 1 |
| Chang, LL | 1 |
| Kan, SF | 1 |
| Ho, LT | 1 |
| Wang, PS | 1 |
| James, VH | 1 |
| Tan, SA | 1 |
| Tan, LG | 1 |
| Smetnik, VP | 1 |
| Komarova, IuA | 1 |
| Hugues, JN | 1 |
| Modigliani, E | 1 |
| Girard, F | 1 |
| Sebaoun, J | 1 |
| Serri, O | 1 |
| O'Malley, BP | 1 |
| Mercey, D | 1 |
| Clarke, E | 1 |
| Maguire, M | 1 |
| Jackson, J | 1 |
| Rosenthal, FD | 1 |
1 review available for aldosterone and Hyperprolactinemia
| Article | Year |
|---|---|
[Premenstrual syndrome].
Topics: Aldosterone; Body Weight; Brain; Dopamine; Endorphins; Estrogens; Female; Humans; Hyperprolactinemia | 1986 |
1 trial available for aldosterone and Hyperprolactinemia
| Article | Year |
|---|---|
The renin-angiotensin-aldosterone axis in patients with nontumoral [corrected] hyperprolactinemia.
Topics: Adult; Aldosterone; Angiotensin II; Bromocriptine; Creatinine; Dopamine Agonists; Female; Humans; Hy | 2011 |
8 other studies available for aldosterone and Hyperprolactinemia
| Article | Year |
|---|---|
Masked hyperprolactinemia in a case of aldosterone-producing adrenal adenoma.
Topics: Adrenal Gland Neoplasms; Aldosterone; Female; Humans; Hyperprolactinemia; Middle Aged | 1995 |
[Role of hypothalamo-hypophyseal-adrenal axis in the pathogenesis of arterial hypertension in patients with prolactinoma of the anterior lobe of the hypophysis].
Topics: Adult; Aldosterone; Bromocriptine; Data Interpretation, Statistical; Dopamine; Dopamine Agonists; Fe | 2000 |
Stimulatory effects of hyperprolactinemia on aldosterone secretion in ovariectomized rats.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenylyl Cyclases; Aldosterone; Alkaloids; Angiotensin II; A | 2002 |
Adrenal steroid endocrinology--some unsolved problems.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Androstenedione; Circadian Rhythm; Dehydro | 1991 |
Hyperiodotyrosinemia-induced hyperprolactinemia and hyperaldosteronism.
Topics: Adult; Aldosterone; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; Epinephrine; Female; | 1990 |
Lack of prolactin involvement in corticosteroid secretion.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex Hormones; Adrenal Glands; Adult; Aldosterone; Cosyntrop | 1987 |
Plasma aldosterone response to metoclopramide is unmodified by hyperprolactinemia.
Topics: Adult; Aldosterone; Female; Humans; Hyperprolactinemia; Metoclopramide; Middle Aged; Pituitary Neopl | 1987 |
Aldosterone responsiveness to metoclopramide in hyperprolactinaemia.
Topics: Aldosterone; Female; Humans; Hyperprolactinemia; Metoclopramide; Prolactin; Thyrotropin | 1987 |